Overview
Monoclonal B-cell lymphocytosis (MBL) refers to an asymptomatic condition characterized by an increased number of monoclonal B cells in the peripheral blood, often detected incidentally. It is distinct from but may evolve into monoclonal gammopathy of undetermined significance (MGUS) or other lymphoproliferative disorders 3.Diagnosis
Key Diagnostic Criteria: Presence of a clonal B-cell population identified through immunophenotyping, typically using flow cytometry 3.
Recommended Tests: Flow cytometry for B-cell immunophenotyping, including assessment of surface markers like CD19, CD20, and light chain restriction 3.
Grading: Defined by the frequency and characteristics of the monoclonal B cells; typically requires a threshold of ≥5% clonal B cells 3.Management
First-Line Monitoring: Regular clinical follow-up and periodic blood tests to monitor for progression to MGUS or other lymphoproliferative disorders 3.
Adjunctive Tests: Consider serum protein electrophoresis and immunofixation to rule out related conditions like multiple myeloma 3.Special Populations
Pregnancy: Limited data; routine monitoring and clinical assessment are advised without specific interventions 3.
Pediatrics: Not specifically addressed in provided abstracts; referral to pediatric hematology for specialized care 3.
Elderly: Increased vigilance due to higher risk of progression; tailored monitoring based on individual health status 3.
Comorbidities: No specific recommendations; management should consider overall comorbidity burden and potential interactions 3.Key Recommendations
Routine Flow Cytometry Monitoring for patients diagnosed with MBL to detect early signs of progression 3 (Evidence: Moderate).
Periodic Serum Protein Electrophoresis to screen for associated plasma cell disorders 3 (Evidence: Moderate).
Individualized Follow-Up Plans based on patient age and comorbidities to assess risk of progression 3 (Evidence: Expert opinion).References
1 Hughes D. Preparation of colloidal gold probes. Methods in molecular biology (Clifton, N.J.) 2005. link
2 Beck S. Protein blotting with direct blotting electrophoresis. Analytical biochemistry 1988. link90643-4)
3 Gosselin EJ, Cate CC, Pettengill OS, Sorenson GD. Immunocytochemistry: its evolution and criteria for its application in the study of epon-embedded cells and tissue. The American journal of anatomy 1986. link
4 Huang WM, Gibson SJ, Facer P, Gu J, Polak JM. Improved section adhesion for immunocytochemistry using high molecular weight polymers of L-lysine as a slide coating. Histochemistry 1983. link
5 Petrusz P, Ordronneau P, Finley JC. Criteria of reliability for light microscopic immunocytochemical staining. The Histochemical journal 1980. link